Skip to main navigation Skip to search Skip to main content

Fractalkine Enhances Hematoma Resolution and Improves Neurological Function via CX3CR1/AMPK/PPARγ Pathway After GMH

  • Xionghui Chen
  • , Xuying He
  • , Feng Xu
  • , Ningbo Xu
  • , Nona Hashem Sharifi
  • , Pengjie Zhang
  • , Jerry J. Flores
  • , Lei Wu
  • , Qiuguang He
  • , Hideki Kanamaru
  • , Shiyi Zhu
  • , Siyuan Dong
  • , Mingyang Han
  • , Ye Yuan
  • , Lei Huang
  • , Liyan Miao
  • , John H. Zhang
  • , Youxin Zhou
  • , Jiping Tang

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2420-2433
Number of pages14
JournalStroke
Volume54
Issue number9
DOIs
StatePublished - Sep 1 2023

ASJC Scopus Subject Areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Keywords

  • CX3C chemokine receptor 1
  • fractalkine
  • hematoma
  • hemorrhage
  • microglia
  • Microglia/metabolism
  • PPAR gamma/metabolism
  • Neuroinflammatory Diseases
  • CX3C Chemokine Receptor 1/metabolism
  • Humans
  • Infant, Newborn, Diseases
  • Rats
  • Chemokine CX3CL1/metabolism
  • Hematoma/metabolism
  • Rats, Sprague-Dawley
  • Animals
  • Cerebral Hemorrhage/drug therapy
  • AMP-Activated Protein Kinases/metabolism
  • Infant, Newborn

Cite this